Trial intelligence / Profile preview

PATRONUS: Amiodarone for Postoperative Atrial Fibrillation in Cardiac Surgery

NCT05543278Phase 4Not yet recruiting

Sponsor
Massachusetts General Hospital
Start
Jan 2027
Primary completion
Jan 2028
Modality
Small Molecules
01

Overview

Phase 4, randomised trial in Atrial fibrillation (AFib) comparing Amiodarone Arm with Standard of Care Arm (2 arms). Primary endpoint: Postoperative atrial fibrillation at 7 days. Planned start Jan 2027; status: not yet recruiting.

02

Drugs

amiodarone
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT05543278.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05543278.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call